GTHP
What one share of Guided Therapeutics holds
Electromedical and Electrotherapeutic Apparatus
We are a medical technology company focused on developing innovative medical devices that have the potential to improve healthcare. Our primary focus is the sales and marketing of our LuViva® Advanced Cervical Scan non-invasive cervical cancer detection device.
Guided Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.01 |
|---|---|
| Profit | −$0.03 |
| Cash and investments | $0.00 |
| Debt | $0.00 |
| Book value | −$0.06 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | $0.01 | −$0.18 | $0.00 | −$0.12 | — | −$0.40 |
| 2022 | $0.00 | −$0.15 | $0.00 | −$0.05 | — | −$0.06 |
| 2023 | $0.00 | −$0.07 | $0.00 | −$0.03 | — | −$0.07 |
| 2024 | $0.00 | −$0.05 | $0.00 | −$0.02 | — | −$0.08 |
| 2025 | $0.01 | −$0.04 | $0.00 | −$0.01 | — | −$0.07 |